Agency Forms Undergoing Paperwork Reduction Act Review, 48148-48149 [2021-18538]
Download as PDF
48148
Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2021–18454 Filed 8–26–21; 8:45 am]
Agency Forms Undergoing Paperwork
Reduction Act Review
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH),
Subcommittee for Dose
Reconstruction Reviews (SDRR),
National Institute for Occupational
Safety and Health (NIOSH);
Cancellation of Meeting
Notice is hereby given of a change in
the meeting of the Advisory Board on
Radiation and Worker Health (ABRWH),
Subcommittee for Dose Reconstruction
Reviews (SDRR); June 16, 2021, from
10:30 a.m. to 2:30 p.m., EDT, in the
original FRN. The teleconference
meeting was published in the Federal
Register on April 23, 2021, Volume 86,
Number 77, pages 21738–21739.
This meeting is being canceled in its
entirety.
FOR FURTHER INFORMATION CONTACT:
lotter on DSK11XQN23PROD with NOTICES1
Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090
Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226, Telephone:
(513) 533–6800, Toll Free 1(800) CDC–
INFO, Email: ocas@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–18455 Filed 8–26–21; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
17:52 Aug 26, 2021
Jkt 253001
[30Day–21–1061]
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Behavioral Risk
Factor Surveillance System (BRFSS), to
the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on March 12, 2021 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Behavioral Risk Factor Surveillance
System (BRFSS) (OMB Control No.
0920–1061, Exp. 3/31/2022)—
Revision—National Center for Chronic
Disease and Public Health Protection
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
CDC is requesting OMB approval to
revise information collection activities
for the Behavioral Risk Factor
Surveillance System (BRFSS) for the
period of 2022–2024. The BRFSS is a
nationwide system of cross-sectional
surveys using random digit dialed
(RDD) samples administered by health
departments in states, territories, and
the District of Columbia (collectively
referred to here as States) in
collaboration with CDC. Traditionally
subject recruitment and interview have
been conducted by telephone. In 2022–
2024, the BRFSS will introduce the
option to allow participants to
voluntarily complete online surveys,
after telephone recruitment. The BRFSS
produces state-level information
primarily on health risk behaviors,
health conditions, and preventive health
practices that are associated with
chronic diseases, infectious diseases,
and injury. Designed to meet the data
needs of individual states and
territories, the CDC sponsors the BRFSS
information collection project under a
cooperative agreement with states and
territories. Under this partnership,
BRFSS state coordinators determine
questionnaire content with technical
and methodological assistance provided
by CDC. For most states and territories,
the BRFSS provides the only sources of
data amenable to state and local level
health and health risk indicator uses.
Over time, it has also developed into an
important data collection system that
federal agencies rely on for state and
local health information and to track
national health objectives such as
Healthy People.
CDC bases the BRFSS questionnaire
on modular design principles to
accommodate a variety of state-specific
needs within a common framework. All
participating states are required to
administer a standardized core
E:\FR\FM\27AUN1.SGM
27AUN1
48149
Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices
questionnaire, which provides a set of
shared health indicators for all BRFSS
partners. The BRFSS core questionnaire
consists of fixed core, rotating core, and
emerging core questions. Fixed core
questions are asked every year. Rotating
core questions cycle on and off the core
questionnaire in two- or three-year
cycles, depending on the question.
Emerging core questions are included in
the core questionnaire as needed to
collect data on urgent or emerging
health topics such as infectious disease.
In addition, the BRFSS includes a series
of optional modules on a variety of
topics. In off years, when the rotating
questions are not included in the core
questionnaire, they are offered to states
as optional modules. This framework
allows each state to produce a
customized BRFSS survey by appending
selected optional modules to the core
survey. States may select which, if any,
optional modules to administer. As
needed, CDC provides technical and
methodological assistance to state
BRFSS coordinators in the construction
of their state-specific surveys. Each state
administers its BRFSS questionnaire
throughout the calendar year.
CDC periodically updates the BRFSS
core survey and optional modules. The
purpose of this Revision request is to
add the following topics to the
questionnaires: COVID vaccination,
impact of the COVID pandemic,
periodontal disease, additional
questions on heart attack and stroke,
disaster/pandemic preparedness,
veterans’ health, and the use of newly
available tobacco products. In addition,
this request seeks approval for
reinstating topics which have been
included in BRFSS in the past,
dependent upon state interest and
funding.
Participation in BRFSS is voluntary
and there is no cost to participate. The
average time burden per response will
be 22 minutes. The total time burden
across all respondents will be
approximately 287,798 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents
Form name
U.S. General Population ..................
Landline Screener .........................................................
Cell Phone Screener .....................................................
Field Test Screener ......................................................
BRFSS Core Survey by Phone Interview .....................
BRFSS Optional Modules by Phone Interview .............
BRFSS Core Survey by Online Survey ........................
BRFSS Optional Modules by Online Survey ................
Field Test Survey by Phone Interview ..........................
Annual Survey Respondents (Adults
>18 Years).
Field Test Respondents (Adults >18
Years).
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–18538 Filed 8–26–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–6063–N7]
Medicare Program; National Expansion
Implementation for All Remaining
States and Territories of the Prior
Authorization Model for Repetitive,
Scheduled Non-Emergent Ambulance
Transports
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice announces the
implementation dates for all remaining
states and territories for the national
expansion of the Prior Authorization
Model for Repetitive, Scheduled NonEmergent Ambulance Transports.
DATES: This expansion of the Prior
Authorization Model for Repetitive,
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:52 Aug 26, 2021
Jkt 253001
Number of
respondents
Scheduled Non-Emergent Ambulance
Transports will begin on December 1,
2021 for independent ambulance
suppliers garaged in Arkansas,
Colorado, Louisiana, Mississippi, New
Mexico, Oklahoma, and Texas; and no
earlier than: February 1, 2022 for
independent ambulance suppliers
garaged in Alabama, American Samoa,
California, Georgia, Guam, Hawaii,
Nevada, Northern Mariana Islands and
Tennessee; April 1, 2022 for
independent ambulance suppliers
garaged in Florida, Illinois, Iowa,
Kansas, Minnesota, Missouri, Nebraska,
Puerto Rico, Wisconsin, and U.S. Virgin
Islands; June 1, 2022 for independent
ambulance suppliers garaged in
Connecticut, Indiana, Maine,
Massachusetts, Michigan, New
Hampshire, New York, Rhode Island,
and Vermont; and August 1, 2022 for
independent ambulance suppliers
garaged in Alaska, Arizona, Idaho,
Kentucky, Montana, North Dakota,
Ohio, Oregon, South Dakota, Utah,
Washington, and Wyoming.
FOR FURTHER INFORMATION CONTACT:
Angela Gaston, (410) 786–7409.
Questions regarding the national
expansion of the Prior Authorization
Model for Repetitive, Scheduled Non-
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
173,000
694,000
900
480,000
440,000
100,000
80,000
500
1
1
1
1
1
1
1
1
Average
burden per
response
(in hours)
1/60
1/60
1/60
15/60
15/60
10/60
10/60
45/60
Emergent Ambulance Transports should
be sent to AmbulancePA@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
In the November 23, 2020 Federal
Register (85 FR 74725), we published a
notice titled ‘‘Medicare Program;
National Expansion of the Prior
Authorization Model for Repetitive,
Scheduled Non-Emergent Ambulance
Transport,’’ which announced the
national expansion of the Prior
Authorization Model for Repetitive,
Scheduled Non-Emergent Ambulance
Transports under section 1834(l)(16) of
the Act, as added by section 515(b) of
the Medicare Access and CHIP
Reauthorization Act of 2015 (MACRA)
(Pub. L. 114–10). The states that
participated in the model under section
1115A of the Social Security Act (the
Act), which included Delaware, the
District of Columbia, Maryland, New
Jersey, North Carolina, Pennsylvania,
South Carolina, Virginia, and West
Virginia, previously transitioned to the
national model on December 2, 2020.
Due to the COVID–19 Public Health
Emergency, we delayed the
implementation of the expansion to any
additional states.
E:\FR\FM\27AUN1.SGM
27AUN1
Agencies
[Federal Register Volume 86, Number 164 (Friday, August 27, 2021)]
[Notices]
[Pages 48148-48149]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18538]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-21-1061]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Behavioral Risk Factor Surveillance System
(BRFSS), to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on March 12,
2021 to obtain comments from the public and affected agencies. CDC did
not receive comments related to the previous notice. This notice serves
to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Behavioral Risk Factor Surveillance System (BRFSS) (OMB Control No.
0920-1061, Exp. 3/31/2022)--Revision--National Center for Chronic
Disease and Public Health Protection (NCCDPHP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC is requesting OMB approval to revise information collection
activities for the Behavioral Risk Factor Surveillance System (BRFSS)
for the period of 2022-2024. The BRFSS is a nationwide system of cross-
sectional surveys using random digit dialed (RDD) samples administered
by health departments in states, territories, and the District of
Columbia (collectively referred to here as States) in collaboration
with CDC. Traditionally subject recruitment and interview have been
conducted by telephone. In 2022-2024, the BRFSS will introduce the
option to allow participants to voluntarily complete online surveys,
after telephone recruitment. The BRFSS produces state-level information
primarily on health risk behaviors, health conditions, and preventive
health practices that are associated with chronic diseases, infectious
diseases, and injury. Designed to meet the data needs of individual
states and territories, the CDC sponsors the BRFSS information
collection project under a cooperative agreement with states and
territories. Under this partnership, BRFSS state coordinators determine
questionnaire content with technical and methodological assistance
provided by CDC. For most states and territories, the BRFSS provides
the only sources of data amenable to state and local level health and
health risk indicator uses. Over time, it has also developed into an
important data collection system that federal agencies rely on for
state and local health information and to track national health
objectives such as Healthy People.
CDC bases the BRFSS questionnaire on modular design principles to
accommodate a variety of state-specific needs within a common
framework. All participating states are required to administer a
standardized core
[[Page 48149]]
questionnaire, which provides a set of shared health indicators for all
BRFSS partners. The BRFSS core questionnaire consists of fixed core,
rotating core, and emerging core questions. Fixed core questions are
asked every year. Rotating core questions cycle on and off the core
questionnaire in two- or three-year cycles, depending on the question.
Emerging core questions are included in the core questionnaire as
needed to collect data on urgent or emerging health topics such as
infectious disease. In addition, the BRFSS includes a series of
optional modules on a variety of topics. In off years, when the
rotating questions are not included in the core questionnaire, they are
offered to states as optional modules. This framework allows each state
to produce a customized BRFSS survey by appending selected optional
modules to the core survey. States may select which, if any, optional
modules to administer. As needed, CDC provides technical and
methodological assistance to state BRFSS coordinators in the
construction of their state-specific surveys. Each state administers
its BRFSS questionnaire throughout the calendar year.
CDC periodically updates the BRFSS core survey and optional
modules. The purpose of this Revision request is to add the following
topics to the questionnaires: COVID vaccination, impact of the COVID
pandemic, periodontal disease, additional questions on heart attack and
stroke, disaster/pandemic preparedness, veterans' health, and the use
of newly available tobacco products. In addition, this request seeks
approval for reinstating topics which have been included in BRFSS in
the past, dependent upon state interest and funding.
Participation in BRFSS is voluntary and there is no cost to
participate. The average time burden per response will be 22 minutes.
The total time burden across all respondents will be approximately
287,798 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
U.S. General Population............... Landline Screener....... 173,000 1 1/60
Cell Phone Screener..... 694,000 1 1/60
Field Test Screener..... 900 1 1/60
Annual Survey Respondents (Adults >18 BRFSS Core Survey by 480,000 1 15/60
Years). Phone Interview. 440,000 1 15/60
BRFSS Optional Modules
by Phone Interview.
BRFSS Core Survey by 100,000 1 10/60
Online Survey.
BRFSS Optional Modules 80,000 1 10/60
by Online Survey.
Field Test Respondents (Adults >18 Field Test Survey by 500 1 45/60
Years). Phone Interview.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-18538 Filed 8-26-21; 8:45 am]
BILLING CODE 4163-18-P